Labcorp (LH) Tops Q3 EPS by 1c; Offers FY22 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Labcorp Announces 2022 Third Quarter Results
October 27, 2022 7:00 AM EDTCompany Updates Full-Year GuidanceÂ
Revenue: Q3 of $3.6 billion versus $4.1 billion last year Diluted EPS: Q3 of $3.90 versus $6.05 last year Adjusted EPS: Q3 of $4.68 versus $6.82 last year Free Cash Flow: Q3 of $270 million versus $650 million last year Progressed Clinical Development business spin-off activities Completed transactions to establish long-term relationship with AscensionÂ
BURLINGTON, N.C.--(BUSINESS WIRE)-- Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the third quarter ended Sept. 30, 2022, and updated full-year... More
